Regulatory mechanism of p53 transcriptional activity by androgen regulated G3BP2 in prostate cancer

被引：0
|
作者：
Takayama, Ken-ichi [1 ]
Inoue, Satoshi [1 ,2 ]
机构：
[1] Tokyo Metro Inst Geron, Func Biogeron, Tokyo, Japan
[2] Saitama Med, Res Ctr Genom, Div Gene Reg Sig Trans, Saitama, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3062
引用
收藏
页码：1110 / 1110
页数：1
相关论文
共 50 条
  • [21] MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
    Li, Haichang
    Lin, Pei-Hui
    Gupta, Pranav
    Li, Xiangguang
    Zhao, Serena Li
    Zhou, Xinyu
    Li, Zhongguang
    Wei, Shengcai
    Xu, Li
    Han, Renzhi
    Lu, Jing
    Tan, Tao
    Yang, Dong-Hua
    Chen, Zhe-Sheng
    Pawlik, Timothy M.
    Merritt, Robert E.
    Ma, Jianjie
    MOLECULAR CANCER, 2021, 20 (01)
  • [22] Androgen-independent growth of human prostate cancer cells is mediated by mutant p53
    Nesslinger, NJ
    Shi, XB
    Gumerlock, PH
    White, RWD
    JOURNAL OF UROLOGY, 2002, 167 (04): : 54 - 54
  • [23] Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status
    Serafin, AM
    Akudugu, JM
    Bohm, L
    UROLOGICAL RESEARCH, 2002, 30 (05): : 289 - 294
  • [24] Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status
    Antonio M. Serafin
    John M. Akudugu
    Lothar Bohm
    Urological Research, 2002, 30 : 289 - 294
  • [25] LMO3 interacts with p53 and inhibits its transcriptional activity
    Larsen, Steven
    Yokochi, Tomoki
    Isogai, Eriko
    Nakamura, Yohko
    Ozaki, Toshinori
    Nakagawara, Akira
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 392 (03) : 252 - 257
  • [26] MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity
    Stindt, Maren H.
    Carter, Stephanie
    Vigneron, Arnaud M.
    Ryan, Kevin M.
    Vousden, Karen H.
    CELL CYCLE, 2011, 10 (18)
  • [27] MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer
    Suh, Seong O.
    Chen, Yi
    Zaman, Mohd Saif
    Hirata, Hiroshi
    Yamamura, Soichiro
    Shahryari, Varahram
    Liu, Jan
    Tabatabai, Z. Laura
    Kakar, Sanjay
    Deng, Guoren
    Tanaka, Yuichiro
    Dahiya, Rajvir
    CARCINOGENESIS, 2011, 32 (05) : 772 - 778
  • [28] Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
    Hudie Wei
    Haolan Wang
    Genxin Wang
    Lingzhi Qu
    Longying Jiang
    Shuyan Dai
    Xiaojuan Chen
    Ye Zhang
    Zhuchu Chen
    Youjun Li
    Ming Guo
    Yongheng Chen
    Nature Communications, 14
  • [29] Differential effect of amifostine on transcriptional activity of mutant p53 in breast cancer cells
    Nayak, Bijaya K.
    Galindo, Cynthia A.
    Meltz, Martin L.
    Herman, Terence S.
    CANCER RESEARCH, 2006, 66 (08)
  • [30] Mxi-2 Dependent Regulation of p53 in Prostate Cancer
    Koeditz, Barbara
    Fries, Jochen W. U.
    Goebel, Heike
    Paffenholz, Pia
    Richter, Konstantin
    Heidenreich, Axel
    Von Brandenstein, Melanie
    ANTICANCER RESEARCH, 2020, 40 (10) : 5539 - 5544
12345